SCHEMBL26687954

SCHEMBL26687954

[CH2]CNC(=O)COc1ccc(C(NC(=O)OCC2c3ccccc3-c3ccccc32)c2ccc(OC)cc2OC)cc1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ MDM2 Q00987 1/20 0.40
▸ KMT2A Q03164 4/20 0.39
▸ MEN1 O00255 3/20 0.39
▸ ADAMTS5 Q9UNA0 2/20 0.38
▸ TP53 P04637 2/20 0.37
▸ MDM4 O15151 1/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ LMNA P02545 2/20 0.37
▸ MAPT P10636 2/20 0.37
▸ CASP3 P42574 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ GAA P10253 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12568257 0.93 RAB9A (0.43) NPC1RAB9AMDM2KMT2AMEN1
SCHEMBL5813924 0.92 NPC1 (0.43) NPC1RAB9AMDM2KMT2AMEN1
SCHEMBL14537676 0.91 NPC1 (0.41) NPC1RAB9AMDM2KMT2AMEN1
SCHEMBL14123991 0.91 NPC1 (0.44) NPC1RAB9AMDM2KMT2AMEN1
SCHEMBL29454419 0.90 NPC1 (0.45) NPC1RAB9AMDM2KMT2AMEN1
SCHEMBL14360219 0.90 NPC1 (0.43) NPC1RAB9AMDM2KMT2AMEN1
SCHEMBL1745934 0.89 KMT2A (0.45) NPC1RAB9AMDM2KMT2AMEN1
SCHEMBL14416300 0.89 KMT2A (0.42) NPC1RAB9AMDM2KMT2AMEN1
SCHEMBL29470540 0.89 KMT2A (0.45) NPC1RAB9AMDM2KMT2AMEN1
SCHEMBL29368397 0.89 KMT2A (0.45) NPC1RAB9AMDM2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023219933-A1 COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACID THERAPEUTICS ENTRADA THERAPEUTICS, INC. (US) 2023-11-16 — — WO disclosed
CN-113861268-A Cell penetrating peptides and methods of making and using the same 恩特拉达治疗学股份有限公司 2021-12-31 — — CN disclosed
CN-106852146-B Cell penetrating peptides and methods of making and using the same 恩特拉达治疗学股份有限公司 2021-08-13 — — CN disclosed
CN-107440928-A Cosmetic composition for improving scalp health and method for producing the same 奥利博思高适美秀迪科思 2017-12-08 — — CN disclosed
CN-106852146-A Cell penetrating peptides and methods of making and using the same 塞克洛波特斯公司 2017-06-13 — — CN disclosed
Send feedback